Kymera Therapeutics remains focused on pipeline progression despite a Q4 revenue miss and widening net loss, supported by a robust $1.6 billion cash position. R&D investment surged to $316.6 million ...

The label highlights the companies’ attention to innovation and forward-looking policies in its eco-friendly PET foam ...

Pipe Network today announced the launch of SolanaCDN, a free, open-source Solana validator client with an integrated CDN ...

CEO of Beiersdorf Vincent Warnery outlined plans to ‘restore momentum’ to Nivea, the German beauty giant’s biggest brand, which fell short of targets in 2025 in a tough market ...

Core Scientific (CORZ) stock dropped 2.8% after missing Q4 revenue estimates with $79.8M vs $122M expected as Bitcoin decline slashed mining revenue by half.

Core Scientific stock falls 2.83% despite 1.5GW expansion. Q4 revenue $79.8M, colocation surges to $31.3M, self-mining drops 57%. Financial restatement disclosed.

Partner demonstrations span product storytelling, simulation planning, and operational training across Unreal Engine and ...

New housing completions and the number of transactions in Romania declined by approximately 5% in 2025 compared with the previous year. Deliveries dropped to their lowest level since 2017, but sales ...

The role of the CMO has evolved into that of growth architect, market translator and strategic integrator across brand, ...

FORT MYERS, Fla. — Johan Oviedo’s first outing of the spring last week didn’t go great, as the right-hander walked three over ...

After decades of building marketing functions from the ground up, one lesson is clear: Tools don’t transform organizations.

Amtagvi revenue growth reached 112% year-over-year, and Proleukin generated about 17% of total revenue for 2025, aligning with prior expectations. The company stated, "The impact of gross to net ...